ClinicalTrials.gg
Drug

Netarsudil clinical trials

Also written Rhopressa.

studies test it
33
open now
5
in phase 3
11
first study started
2012

How each study uses netarsudil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the netarsudil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Dec 2017 · RHOPRESSA · NDA 208254 (FDA, Drugs@FDA)
European Union
19 Nov 2019 · Rhokiinsa · EMEA/H/C/004583 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Netarsudil
9
AR-13324 Ophthalmic Solution 0.02%
7
Netarsudil ophthalmic solution 0.02%
6
Netarsudil Ophthalmic
5
Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution
3

Brand

Rhopressa
10

Development codes

PG324
1
AR-13324
1

Studies by the year they started

33 studies that test it; most in 2025 (6)

Studies that test netarsudil, by start year
YearStudies
20122
20131
20143
20152
20161
20173
20182
20193
20203
20212
20221
20231
20241
20256
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
3
Phase 2
12
Phase 3
11
Phase 4
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 14

Aerie Pharmaceuticals (16) · Massachusetts Eye and Ear Infirmary (3) · Price Vision Group (2) · East Coast Institute for Research (1) · University Hospital Dubrava (1) · Alcon Research (1) · Westlake Eye Specialists (1) · Cornea Research Foundation of America (1)

Often tested with

Tested in the same studies.

Bimatoprost (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test netarsudil.

Studies

Open first, then newest update. How each study uses netarsudil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 33

See all 33 studies that test netarsudil →

Given beside what is tested · 1 — netarsudil is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with netarsudil

Codes

What other systems call netarsudil · ClinicalTrials.gg INT000366

  • MeSH (NLM) C000603944netarsudilOne source NLM
  • UNII (FDA) W6I5QDT7QINETARSUDILConfirmed FDA, NLM, Wikidata
  • RxNorm 1992864One source FDA
  • Wikidata Q27292390netarsudilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C170213NetarsudilOne source FDA
  • DrugBank DB13931One source Wikidata

Also registered as netarsudil mesylate (UNII VL756B1K0U · RxNorm 1992863).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.